Total Pageviews

Wednesday, November 7, 2012

Therapeutic lymphangiogenesis with implantation of adipose-derived regenerative cells.

Therapeutic lymphangiogenesis with implantation of adipose-derived regenerative cells.

Aug 2012

Source

Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.

Abstract


BACKGROUND:

Lymphedema is one of the serious clinical problems that can occur after surgical resection of malignant tumors such as breast cancer or intra-pelvic cancers. However, no effective treatment options exist at present. Here, we report that implantation of adipose-derived regenerative cells (ADRCs) can induce lymphangiogenesis in a mouse model of reparative lymphedema.

METHODS AND RESULTS:

 ADRCs were isolated from C57BL/6J mice. To examine the therapeutic efficacy of ADRC  implantation in vivo, we established a new mouse model of tail lymphedemaLymphedema was improved significantly by local injection of ADRCs. Histological analysis revealed that lymphatic capillary density was greater in the ADRC group than in the phosphate-buffered saline control group. Tissue expression of vascular endothelial growth factor C mRNA and plasma levels of vascular endothelial growth factor C  ADRCs released vascular endothelial growth factor C, which directly stimulated lymphangiogenesis. Implantation of ADRCs also enhanced recruitment of bone marrow-derived M2 macrophages, which served as lymphatic endothelial progenitor cells.

CONCLUSIONS:

Implantation of autologous ADRCs could be a useful treatment option for patients with severe lymphedema.

PubMed

No comments: